TrialClinical cardiology2005

Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia.

Hsin-Bang Leu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.